6月1日，Veeva Systems盘中上涨5.5%，报185.419美元/股，成交额6657.77万美元。
消息面上，公司近期连续披露多项利好：Teva Pharmaceutical与Merck KGaA宣布全球采用其Vault CRM平台，CDMO企业Kindeva签约Veeva质量云，同时公司发布药物研发代理平台Falcon，展现AI布局能力。多重客户签约与新品叠加，市场对公司增长动能预期进一步增强。此外，公司将于6月3日盘后发布新季度财报，机构预期营收同比增长约16.62%，调整后每股收益1.55美元，财报前资金提前布局亦为股价提供支撑。
Veeva Systems成立于2007年，是全球生命科学行业领先的行业云解决方案提供商，产品涵盖云软件、数据和业务咨询，服务覆盖从研发到商业化的全流程。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.